Home/Filings/4/0001562180-23-001800
4//SEC Filing

Lai Quintin J 4

Accession 0001562180-23-001800

CIK 0000105770other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 6:30 PM ET

Size

7.1 KB

Accession

0001562180-23-001800

Insider Transaction Report

Form 4
Period: 2023-02-21
Lai Quintin J
VP Corp Development & Strategy
Transactions
  • Award

    Stock Options (Right to buy)

    2023-02-21+1,7241,724 total
    Exercise: $306.68From: 2024-02-21Exp: 2033-02-21Stock Options (Right to Buy) (1,724 underlying)
  • Award

    Common Stock

    2023-02-21$306.68/sh+1,134$347,77518,306.93 total
Footnotes (2)
  • [F1]2020 PSUs (PP19) award vesting net of taxes withheld
  • [F2]This award vests in four equal annual installments beginning on February 21, 2024.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001744326

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:30 PM ET
Size
7.1 KB